Latest news

We develop solutions for important global health issues

Quadrant Biosciences is a molecular diagnostics company with a focus on the early detection of neurological disorders and other large-scale health issues. Revolutionary  advancements in the early detection of autism spectrum disorder, Parkinson’s disease and mTBI,  through the application of the Clarifi® Dx molecular diagnostic platform, could have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions.

Additionally, we are involved in three significant, complementary COVID-19 projects to aid in the detection of COVID-19 in individuals and communities across the U.S.

Developing solutions for important global health issues
Collage Square

Be part of a study

Autism research study

Children ages 18 months to 48 months with an autism diagnosis, developmental delays, or a suspicion of autism are eligible.

Parkinson’s Study

Help us learn how to better diagnose Parkinson’s Disease at an earlier stage.